CCM
LEGN icon

Cutter Capital Management’s Legend Biotech LEGN Stock Holding History

Cutter Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-325,953
Closed -$15.9M – 34
2024
Q3 		$15.9M Sell
325,953
-17,177
-5% -$915K 4.69% 6
2024
Q2 		$15.2M Buy
343,130
+263,300
+330% +$12.1M 4.59% 9
2024
Q1 		$4.48M Buy
+79,830
New +$4.81M 1.71% 22

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cutter Capital Management's LEGN Position: Q4 2024 in Review

Cutter Capital Management sold out of Legend Biotech (LEGN) in Q4 2024, closing a stake of 325,953 shares — an estimated $15.9M sold.

Cutter Capital Management first reported a position in LEGN in Q1 2024 and held it in 3 quarters. The position peaked at $15.9M in Q3 2024. 210 funds tracked by Wall St. Rank hold LEGN as of Q4 2024.

  • Cutter Capital Management reported no remaining Legend Biotech position as of Q4 2024 after selling out during the quarter.
  • Cutter Capital Management sold 325,953 Legend Biotech shares in Q4 2024, an estimated $15.9M.
  • Cutter Capital Management first reported a position in Legend Biotech in Q1 2024 and held it in 3 quarters.
  • Cutter Capital Management's Legend Biotech position peaked at $15.9M in Q3 2024.
  • 210 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2024.

Based on Cutter Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.